By Rady Ananda
Originally posted at Global Research.
“A new invention to poison people … is not a patentable invention.” Lowell v. Lewis, 1817
A landmark lawsuit filed on March 29 in US federal court seeks to invalidate Monsanto’s patents on genetically modified seeds and to prohibit the company from suing those whose crops become genetically contaminated.
The Public Patent Foundation filed suit on behalf of 270,000 people from sixty organic and sustainable businesses and trade associations, including thousands of certified-organic farmers.
“As Justice Story wrote in 1817, to be patentable, an invention must not be ‘injurious to the well being, good policy, or sound morals of society,’” notes the complaint in its opening paragraphs.
Posted in Bioweaponry, FDA, USDA, Food & Farming, Genetic Engineering, Obama and Company
Tagged BASF, bayer, biotechnology, Dow, dupont, Monsanto, Organic, Organic Seed Growers and Trade Association, OSGTA, pharma crops, public patent foundation, pubpat, seed monopoly, syngenta, the idiot cycle
Wall Street cannot see that a regime change has come to the markets, one in which corporations will be increasingly on the defensive, hounded by governments everywhere looking to raise tax revenue, and assaulted by a permanent buyers strike from consumers adjusting to their own drop in living standards. Image
The financial press likes to talk up those occasions when the Dow presses on above 10,000. Such talk lately has become desultory, since it seems every other week the Dow lurches below 10,000 and then manages to climb its way back up. The market has been in this funk since February of this year, when the Dow began its most recent push from below 10,000, all the way to a peak around 11,200, only to fall three times below the 10,000 level since and recover with less and less conviction.